{"id":40566,"date":"2025-05-13T16:55:52","date_gmt":"2025-05-13T11:25:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=40566"},"modified":"2025-05-13T17:21:20","modified_gmt":"2025-05-13T11:51:20","slug":"accretion-pharmaceuticals-ipo","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/","title":{"rendered":"Accretion Pharmaceuticals IPO GMP &#038; Review: Apply or Avoid?"},"content":{"rendered":"<p><strong>Accretion Pharmaceuticals IPO<\/strong> is all set to open for bidding on 14th May 2025. It is a bookbuilding IPO consisting of a fresh issue of 29.46 lakh shares worth \u20b929.75 crores. The issue will be listed on NSE and SME on its tentative listing date, 21st May 2025.\u00a0<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_Details\" title=\"Accretion Pharmaceuticals IPO Details&nbsp;\">Accretion Pharmaceuticals IPO Details&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_Share_Reservation\" title=\"Accretion Pharmaceuticals IPO Share Reservation\">Accretion Pharmaceuticals IPO Share Reservation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_GMP_Grey_Market_Premium\" title=\"Accretion Pharmaceuticals IPO GMP Grey Market Premium\">Accretion Pharmaceuticals IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_Review\" title=\"Accretion Pharmaceuticals IPO Review\">Accretion Pharmaceuticals IPO Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Financial_Health\" title=\"Financial Health\">Financial Health<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Technical_Analysis\" title=\"Technical Analysis\">Technical Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_Limited_Peer_Comparison\" title=\"Accretion Pharmaceuticals Limited Peer Comparison\">Accretion Pharmaceuticals Limited Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_Subscription_Status\" title=\"Accretion Pharmaceuticals IPO Subscription Status\">Accretion Pharmaceuticals IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#About_Accretion_Pharmaceuticals_Limited\" title=\"About Accretion Pharmaceuticals Limited\">About Accretion Pharmaceuticals Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_Limited_Financials\" title=\"Accretion Pharmaceuticals Limited Financials\">Accretion Pharmaceuticals Limited Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_Bidding_Requirements\" title=\"Accretion Pharmaceuticals IPO Bidding Requirements\">Accretion Pharmaceuticals IPO Bidding Requirements<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Accretion_Pharmaceuticals_IPO_Promoter_Holdings\" title=\"Accretion Pharmaceuticals IPO Promoter Holdings\">Accretion Pharmaceuticals IPO Promoter Holdings<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Aim_of_Accretion_Pharmaceuticals_IPO\" title=\"Aim of Accretion Pharmaceuticals IPO\">Aim of Accretion Pharmaceuticals IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Should_I_Invest_in_Accretion_Pharmaceuticals_IPO\" title=\"Should I Invest in Accretion Pharmaceuticals IPO?\">Should I Invest in Accretion Pharmaceuticals IPO?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Pros_of_Accretion_Pharmaceuticals_IPO\" title=\"Pros of Accretion Pharmaceuticals IPO\">Pros of Accretion Pharmaceuticals IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Cons_of_Accretion_Pharmaceuticals_IPO\" title=\"Cons of Accretion Pharmaceuticals IPO\">Cons of Accretion Pharmaceuticals IPO<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#How_to_Apply_for_Accretion_Pharmaceuticals_IPO\" title=\"How to Apply for Accretion Pharmaceuticals IPO?\">How to Apply for Accretion Pharmaceuticals IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#How_to_Check_Accretion_Pharmaceuticals_IPO_Allotment_Status\" title=\"How to Check Accretion Pharmaceuticals IPO Allotment Status?\">How to Check Accretion Pharmaceuticals IPO Allotment Status?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Check_On_NSE\" title=\"Check On NSE\">Check On NSE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Check_On_the_Registrar_Portal\" title=\"Check On the Registrar Portal\">Check On the Registrar Portal<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Lets_Wrap\" title=\"Let\u2019s Wrap\">Let\u2019s Wrap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#FAQs_on_Accretion_Pharmaceuticals_IPO\" title=\"FAQs on Accretion Pharmaceuticals IPO\">FAQs on Accretion Pharmaceuticals IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#How_is_Accretion_Pharmaceuticals_IPO\" title=\"How is Accretion Pharmaceuticals IPO?\">How is Accretion Pharmaceuticals IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#What_is_Accretion_Pharmaceuticals_IPO_price\" title=\"What is Accretion Pharmaceuticals IPO price?\">What is Accretion Pharmaceuticals IPO price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Is_Accretion_Pharmaceuticals_IPO_good\" title=\"Is Accretion Pharmaceuticals IPO good?\">Is Accretion Pharmaceuticals IPO good?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Who_is_the_registrar_of_the_Accretion_Pharmaceuticals_IPO\" title=\"Who is the registrar of the Accretion Pharmaceuticals IPO?\">Who is the registrar of the Accretion Pharmaceuticals IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#What_is_the_issue_size_of_the_Accretion_Pharmaceuticals_IPO\" title=\"What is the issue size of the Accretion Pharmaceuticals IPO?&nbsp;\">What is the issue size of the Accretion Pharmaceuticals IPO?&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Read_Our_Articles_on_the_Best_Stocks\" title=\"Read Our Articles on the Best Stocks\">Read Our Articles on the Best Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Also_Explore\" title=\"Also Explore\">Also Explore<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Explore_Current_and_Previous_IPOs\" title=\"Explore Current and Previous IPOs\">Explore Current and Previous IPOs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Univest_Screeners\" title=\"Univest Screeners\">Univest Screeners<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/univest.in\/blogs-2\/accretion-pharmaceuticals-ipo\/#Explore_Webstories_on_Univest\" title=\"Explore Webstories on Univest&nbsp;\">Explore Webstories on Univest&nbsp;<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Details\"><\/span><strong>Accretion Pharmaceuticals IPO Details&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Pharmaceuticals IPO date is fixed between 14th May 2025 and 16th May 2025. The face value of Accretion Pharmaceuticals Limited shares stands at \u20b910 per share, and the IPO price band is fixed between \u20b996 to \u20b9101 per share.&nbsp;<\/p><p>Kfin Technologies Limited is the registrar of Accretion Pharmaceuticals IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest <a href=\"https:\/\/univest.in\/blogs\/what-is-an-ipo\">IPO<\/a> details in the table below.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>14th May 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>16th May 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>19th May 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>20th May 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>29,46,000 shares (worth \u20b929.75 crore)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>1,200 shares<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b996 to \u20b9101 per share<\/td><\/tr><tr><td><strong>Market Makers Portion<\/strong><\/td><td>1,47,600 shares<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>NSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>21st May 2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Share_Reservation\"><\/span><strong>Accretion Pharmaceuticals IPO Share Reservation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Pharmaceuticals IPO<strong> <\/strong>is a bookbuilding issue of 29.46 lakh shares worth \u20b929.75 crore. Accretion Pharmaceuticals Limited shares will be listed on the NSE and SME. Furthermore, SEBI has specified the share reservation criteria for different investor categories.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Investor Categories<\/strong><\/td><td><strong>Reservation Required&nbsp;<\/strong><\/td><\/tr><tr><td><strong>Retail Investors<\/strong><\/td><td>&gt;50.00% of the net offer<\/td><\/tr><tr><td><strong>NII Shares Offered<\/strong><\/td><td>&lt;15.00% of the net offer<\/td><\/tr><tr><td><strong>QIB Shares Offered<\/strong><\/td><td>&lt;35.00% of the net offer<\/td><\/tr><tr><td><strong>Total<\/strong><\/td><td><strong>100.00%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Accretion Pharmaceuticals IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>GMP is the gap between the price band of the issue and the price at which company shares are currently trading in the grey market. Do you want to get live updates on <strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP<\/strong>? If yes, then you\u2019ve reached the right spot. Check the table below to learn about the GMP trends.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>13-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>0<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>12-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>0<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>11-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>0<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><tr><td><strong>10-05-2025<\/strong><\/td><td>\u20b9101<\/td><td>0<\/td><td>\u20b9101<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><p>As of 13th May 2025, <strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP<\/strong> stands at \u20b90 per share, which means the share will likely show a flat listing at \u20b9101 (101+0) on its tentative listing date, 21st May 2025.<\/p><p>GMP data is subject to change based on market trends and sentiments. You should check the live GMP status before applying for the Accretion Pharmaceuticals IPO. Stay informed with Univest to know about real-time insights on IPOs and their GMP trends.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Review\"><\/span><strong>Accretion Pharmaceuticals IPO Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-1024x536.jpg\" alt=\"\" class=\"wp-image-40580\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Check out the detailed <strong>Accretion Pharmaceuticals IPO<\/strong><strong> <\/strong>review<strong> <\/strong>for a thorough understanding of its potential to report listing gains on 21st May 2025. The <strong>Accretion Pharmaceuticals IPO<\/strong> review below will help you invest effectively to avoid significant losses. Explore more to make informed investment decisions on this IPO.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Financial_Health\"><\/span><strong>Financial Health<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Assess a company&#8217;s financial performance to know about its ability to sustain a competitive edge. Thus, it is essential to understand the growth margins and declines of the business financials before applying for the Accretion Pharmaceuticals IPO.<\/p><p>Accretion Pharmaceuticals Limited&#8217;s revenue rose 14.93% from \u20b929.53 crores in March 2023 to \u20b933.94 crores in March 2024. Moreover, the company&#8217;s PAT increased by 3,780.00% from \u20b90.10 crores to \u20b93.88 crores.&nbsp;<\/p><p>Accretion Pharmaceuticals Limited<strong> <\/strong>has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for <strong>Accretion Pharmaceuticals IPO<\/strong><strong> <\/strong>for its tentative listing day, which is 21st May 2025.&nbsp;&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Analysis\"><\/span><strong>Technical Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>A number of technical indicators are available to assess a company&#8217;s potential to deliver returns. Use the parameters mentioned below to analyse the technicals of Accretion Pharmaceuticals IPO.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)&nbsp;<\/strong><\/a><\/td><td>21.29<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>4.74<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>72.47%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-equity\"><strong>ROE<\/strong><\/a><strong> (Return on Equity)<\/strong><\/td><td>72.47%<\/td><\/tr><tr><td><strong>ROCE<\/strong><\/td><td>36.73%<\/td><\/tr><tr><td><strong>PAT Margin (Profit After Tax)<\/strong><\/td><td>11.51<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9112.27 crore<\/td><\/tr><\/tbody><\/table><\/figure><p>The PE ratio of Accretion Pharmaceuticals Limited shares is 21.29, and its Earnings Per Share (EPS) stands at 4.74. The Accretion Pharmaceuticals IPO can potentially deliver gains on its tentative listing date, 21st May 2025.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_Limited_Peer_Comparison\"><\/span><strong>Accretion Pharmaceuticals Limited Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company Name<\/strong><\/td><td><strong>Revenue (in cr.)<\/strong><\/td><td><strong>PE Ratio<\/strong><\/td><td><strong>Face Value (in Rs)<\/strong><\/td><td><strong>EPS&nbsp;<\/strong><\/td><td><strong>RoNW (in %)<\/strong><\/td><\/tr><tr><td><strong>Accretion Pharmaceuticals Ltd.<\/strong><\/td><td>33.94<\/td><td>21.29<\/td><td>10<\/td><td>4.74<\/td><td>72.47%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/univest.in\/stocks\/sakar\/sakar-healthcare-ltd-share-price-today\">Sarkar Healthcare Limited<\/a><\/strong><\/td><td>156.53<\/td><td>45.04<\/td><td>10<\/td><td>6.77<\/td><td>13.57%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/univest.in\/stocks\/lincoln\/lincoln-pharmaceuticals-ltd-share-price-today\">Lincoln Pharmaceuticals Limited<\/a><\/strong><\/td><td>142.49&nbsp;<\/td><td>12.85<\/td><td>10<\/td><td>44.62<\/td><td>15.74%<\/td><\/tr><tr><td><strong><a href=\"https:\/\/univest.in\/stocks\/sotac\/sotac-pharmaceuticals-ltd-share-price-today\">Sotac Pharmaceuticals Limited<\/a><\/strong><\/td><td>104.09<\/td><td>30.93<\/td><td>10<\/td><td>4.04<\/td><td>43.47%<\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of <\/em><em>Accretion Pharmaceuticals <\/em><em>Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>21.29<\/td><td>16.08<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>4.74<\/td><td>6.28<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Subscription_Status\"><\/span><strong>Accretion Pharmaceuticals IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>Accretion Pharmaceuticals IPO<\/strong> is now open for bidding on 14th May 2025. The subscription status for this IPO is yet to be announced. Stay informed on this passage to check the live Accretion Pharmaceuticals IPO Subscription Status.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Investor Category<\/strong><\/td><td><strong>Shares Offered<\/strong><\/td><td><strong>Shares Subscribed<\/strong><\/td><td><strong>Subscription in Times<\/strong><\/td><\/tr><tr><td><strong>Retail Investors<\/strong><\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><tr><td><strong>QIB<\/strong><\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><tr><td><strong>NII (sNII+bNII)<\/strong><\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><tr><td><strong>Market Maker<\/strong><\/td><td>1,47,600<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><tr><td><strong>Total<\/strong><\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><td>Yet to be announced<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Accretion_Pharmaceuticals_Limited\"><\/span><strong>About Accretion Pharmaceuticals Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-1024x536.jpg\" alt=\"\" class=\"wp-image-40582\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p><a href=\"https:\/\/accretionpharma.com\/\" rel=\"nofollow noopener\" target=\"_blank\">Accretion Pharmaceuticals Limited<\/a> was incorporated in 2012, manufacturing and selling tablets, capsules, and other healthcare products. It also offers contract manufacturing services and markets other tablets such as Oral Liquids, External Preparations, and Oral Powder. Accretion Pharmaceuticals Limited holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications. Here are the major competitive strengths of Accretion Pharmaceuticals Limited.\u00a0<\/p><ul class=\"wp-block-list\"><li>Experienced Promoters and Management Team.<\/li>\n\n<li>Long-standing relationship with clients and suppliers.<\/li>\n\n<li>Focus on providing quality products.<\/li>\n\n<li>Management has built a supply chain and customer relations, creating goodwill and trust.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_Limited_Financials\"><\/span><strong>Accretion Pharmaceuticals Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the Accretion Pharmaceuticals IPO. Look at the table to learn about Accretion Pharmaceuticals Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>31st October 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><td><strong>31st March 2022 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>39.99<\/td><td>27.05<\/td><td>20.58<\/td><td>17.74<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>35.75<\/td><td>33.94<\/td><td>29.53<\/td><td>22.58<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>5.24<\/td><td>3.88<\/td><td>0.10<\/td><td>0.08<\/td><\/tr><tr><td><strong>Debt<\/strong><\/td><td>13.79<\/td><td>13.48<\/td><td>8.47<\/td><td>7.61<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>13.58<\/td><td>5.35<\/td><td>3.84<\/td><td>3.08<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Pharmaceuticals Limited&#8217;s revenue rose 14.93% from \u20b929.53 crores in March 2023 to \u20b933.94 crores in March 2024. Moreover, the company&#8217;s PAT increased by 3,780.00% from \u20b90.10 crores to \u20b93.88 crores.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Bidding_Requirements\"><\/span><strong>Accretion Pharmaceuticals IPO Bidding Requirements<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Pharmaceuticals IPO has reserved lot sizes to be applied by different investor categories. Look at the table below to know about the requirements to be fulfilled for applying for this IPO.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Investor Category<\/strong><\/td><td><strong>Lots<\/strong><\/td><td><strong>Shares<\/strong><\/td><td><strong>Amount (in Rs)<\/strong><\/td><\/tr><tr><td>Retail (Minimum)<\/td><td>1<\/td><td>1,200 shares<\/td><td>\u20b91,21,200<\/td><\/tr><tr><td>Retail (Maximum)<\/td><td>1<\/td><td>1,200 shares<\/td><td>\u20b91,21,200<\/td><\/tr><tr><td>HNIs (Minimum)<\/td><td>2<\/td><td>2,400 shares<\/td><td>\u20b92,42,400<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Pharmaceuticals_IPO_Promoter_Holdings\"><\/span><strong>Accretion Pharmaceuticals IPO Promoter Holdings<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Have a look at the table below to check the holdings of Accretion Pharmaceuticals Limited\u2019s promoters: Mr. Mayur Popatlal, Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, and Mr. Hardik Mukundbhai Prajapati.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Share Holding Pre-Issue<\/strong><\/td><td>100.00%<\/td><\/tr><tr><td><strong>Share Holding Post-Issue<\/strong><\/td><td>73.48%<\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Note<\/em><\/strong><em>: Promoter Holdings&#8217; value is to be calculated using Equity dilution, which represents the gap between shareholdings before and after the Issue.&nbsp;<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aim_of_Accretion_Pharmaceuticals_IPO\"><\/span><strong>Aim of Accretion Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the Accretion Pharmaceuticals IPO is to raise \u20b929.75 crores. On the other hand, Accretion Pharmaceuticals Limited has decided to utilise these funds in different practices. Explore some of the secondary objectives for the Accretion Pharmaceuticals IPO.<\/p><ul class=\"wp-block-list\"><li>To meet capital expenditure on machinery and equipment.<\/li>\n\n<li>To meet general corporate purposes.&nbsp;<\/li>\n\n<li>To meet the repayment of certain borrowings availed by the company.<\/li>\n\n<li>To meet the working capital requirements of the company.&nbsp;<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Should_I_Invest_in_Accretion_Pharmaceuticals_IPO\"><\/span><strong>Should I Invest in Accretion Pharmaceuticals IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><em>\u201c<\/em><em>Accretion Pharmaceuticals Limited is engaged in the marketing and manufacturing of pharma products. It is largely operating on a B2B model. Spurt in its bottom lines from FY24 raise eyebrows and concern over its sustainability. It does contract manufacturing business that has large volume but less margins. Based on its financial data, the issue appears aggressively priced. Well-informed investors may park funds for long term.<\/em><em>\u201d <\/em>~ Dilip Davda (Editor at Chittorgarh Infotech Private Limited)<\/p><p>Explore the pros and cons of Accretion Pharmaceuticals IPO to know whether you should apply or avoid the issue. These pros and cons might help you know about the IPO\u2019s efficiency in delivering profits in the coming decades.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Pros_of_Accretion_Pharmaceuticals_IPO\"><\/span><strong><\/strong><strong>Pros of <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Experienced Promoters and Management.<\/li>\n\n<li>Delivering Quality Products.<\/li><\/ul><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cons_of_Accretion_Pharmaceuticals_IPO\"><\/span><strong>Cons of <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Low Employee Base.<\/li>\n\n<li>Less Margins.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_to_Apply_for_Accretion_Pharmaceuticals_IPO\"><\/span><strong>How to Apply for Accretion Pharmaceuticals IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-1024x536.jpg\" alt=\"\" class=\"wp-image-40583\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>Check the steps mentioned below to apply for the Accretion Pharmaceuticals IPO.&nbsp;<\/p><ul class=\"wp-block-list\"><li><strong>Step 1<\/strong>: Conduct thorough research on Accretion Pharmaceuticals IPO GMP, subscription status, issue size, lot size, and other details.&nbsp;<\/li>\n\n<li><strong>Step 2<\/strong>: Open a <a href=\"https:\/\/univest.in\/blogs\/demat-account\"><strong>demat account on Univest<\/strong><\/a> to learn about real-time insights on GMP and subscription status. You can also use your previous demat account by navigating to the IPO section.&nbsp;<\/li>\n\n<li><strong>Step 3<\/strong>: Make a bid for one lot of 1,200 shares worth \u20b91,21,200 of the Accretion Pharmaceuticals IPO.&nbsp;&nbsp;&nbsp;<\/li>\n\n<li><strong>Step 4<\/strong>: You will receive a mandate request after making a bid. Approve the request to proceed further.&nbsp;&nbsp;&nbsp;&nbsp;<\/li><\/ul><p><strong><em>Note<\/em><\/strong><em>: You can apply for the <\/em><em>Accretion Pharmaceuticals IPO<\/em><strong><em> <\/em><\/strong><em>from more than one demat account to increase your allotment chances.&nbsp;<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_to_Check_Accretion_Pharmaceuticals_IPO_Allotment_Status\"><\/span><strong>How to Check Accretion Pharmaceuticals IPO Allotment Status?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>You can check for the Accretion Pharmaceuticals IPO allotment in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Check_On_NSE\"><\/span><strong><\/strong><strong>Check On NSE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Visit the <a href=\"https:\/\/www.nseindia.com\/\" rel=\"nofollow noopener\" target=\"_blank\"><strong>NSE Official Website<\/strong><\/a>.<\/li>\n\n<li>Navigate to the IPO Allotment Section.&nbsp;<\/li>\n\n<li>Select Equity as the issue type.&nbsp;<\/li>\n\n<li>Choose the <strong>Accretion Pharmaceuticals IPO<\/strong>.&nbsp;&nbsp;<\/li>\n\n<li>Choose whether to proceed with the PAN number or the application number.<\/li>\n\n<li>Submit your details to get the allotment status online.&nbsp;<\/li><\/ul><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Check_On_the_Registrar_Portal\"><\/span><strong><\/strong><strong>Check On the Registrar Portal<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ul class=\"wp-block-list\"><li>Visit the <a href=\"https:\/\/kosmic.kfintech.com\/ipostatus\/\" rel=\"nofollow noopener\" target=\"_blank\"><strong>registrar portal<\/strong><\/a>.&nbsp;<\/li>\n\n<li>Click on the allotment option.<\/li>\n\n<li>Fill in the required details.<\/li>\n\n<li>Click on the submit button to know your Accretion Pharmaceuticals IPO allotment status.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Lets_Wrap\"><\/span><strong>Let\u2019s Wrap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>Accretion Pharmaceuticals IPO<\/strong><strong> <\/strong>is a bookbuilding issue of 29.46 lakh shares worth \u20b929.75 crores. The shares of Accretion Pharmaceuticals Limited will be listed on NSE and SME on its tentative listing date of 21st May 2025. Researching <strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP <\/strong>and reviews is highly suggested to book your ideal profitability. Brokers and investors have highlighted their pros and cons, so one must analyse them and decide accordingly.<\/p><p><em>Open a demat account on Univest now to initiate your investment journey!<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Accretion_Pharmaceuticals_IPO\"><\/span><strong>FAQs on Accretion Pharmaceuticals IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_is_Accretion_Pharmaceuticals_IPO\"><\/span><strong>How is <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong>?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Currently, on 13th May 2025, <strong>Accretion Pharmaceuticals IPO<\/strong><strong> GMP<\/strong> (Grey Market Premium) stands at \u20b90 (0.00 % up). It indicates that the estimated listing price could be \u20b9101 per share. It is entirely a fresh issue of 29.46 lakh shares worth \u20b929.75 crore. The IPO issue price is set between \u20b996 to \u20b9101 per share, and the face value of each share is \u20b910.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_Accretion_Pharmaceuticals_IPO_price\"><\/span><strong>What is <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong> price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. The <strong>Accretion Pharmaceuticals IPO<\/strong> price band is set between \u20b996 and \u20b9101 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 1,200 shares worth \u20b91,21,200. Moreover, HNIs are required to bid for a minimum of 2 lots (2,400 shares) worth \u20b92,42,400.&nbsp;<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Accretion_Pharmaceuticals_IPO_good\"><\/span><strong>Is <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong> good?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. During FY23- 24, Accretion Pharmaceuticals Limited&#8217;s revenue rose 14.93% from \u20b929.53 crores in March 2023 to \u20b933.94 crores in March 2024. Moreover, the company&#8217;s PAT increased by 3,780.00% from \u20b90.10 crores to \u20b93.88 crores.&nbsp; However, industry experts suggest applying for this IPO with a long-term perspective.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_the_Accretion_Pharmaceuticals_IPO\"><\/span><strong>Who is the registrar of the <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong>?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Kfin Technologies Limited is the registrar of <strong>Accretion Pharmaceuticals IPO<\/strong><strong>,<\/strong> awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Accretion Pharmaceuticals IPO allotment and refund, you can contact Kfin Techologies Limited at <a href=\"mailto:reachus@kfintech.com\">reachus@kfintech.com<\/a> or 04067162222, 04079611000.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_size_of_the_Accretion_Pharmaceuticals_IPO\"><\/span><strong>What is the issue size of the <\/strong><strong>Accretion Pharmaceuticals IPO<\/strong><strong>?&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Ans. Accretion Pharmaceuticals IPO is a bookbuilding IPO for 29.46 lakh shares worth \u20b929.75 crore. It is entirely a fresh issue. Moreover, the IPO is set to open on 14th May 2025 and will be closed on 16th May 2025.&nbsp;<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the <\/em><em>Accretion Pharmaceuticals IPO<\/em><em>, download the <\/em><em>Accretion Pharmaceuticals IPO<\/em><em> RHP and <\/em><em>Accretion Pharmaceuticals IPO<\/em><em> DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Read_Our_Articles_on_the_Best_Stocks\"><\/span><strong>Read Our Articles on the Best Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/gold-stocks\">Best Gold Stocks India<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/green-energy-penny-stocks\">Green Energy Penny Stocks<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/cement-stocks\">Best Cement Stocks To Invest in India<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\">What is Earnings Per Share EPS?&nbsp;<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/best-multibagger-penny-stocks-for-2025\">Top Multibagger Penny Stocks For 2025 |&nbsp; Potential Picks<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/fundamentally-strong-stocks-on-nse\">Fundamentally Strong Stocks on NSE in 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/debt-free-penny-stocks\">Debt-Free Penny Stocks in India 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/realty-stocks\">Best Realty Stocks In India 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/debt-free-penny-stocks-below-1-rupee\">Debt Free Penny Stocks Below 1 Rupee<\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Also_Explore\"><\/span><strong>Also Explore<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Best Stocks&nbsp;<\/strong><\/td><td><strong>Multibagger Stocks&nbsp;<\/strong><\/td><td><strong>Penny Stocks<\/strong><\/td><td><strong>Fundamentally Strong Stocks&nbsp;<\/strong><\/td><td><strong>Sector Wise Stocks<\/strong><\/td><td><strong>PSU \/Government Stocks<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-indian-stocks-for-next-10-years\">For Next 10 Years<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-stocks-for-next-5-years\">For Next 5 Years<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/solar-penny-stocks\">Solar Penny Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/fundamentally-strong-stocks-bse\">On BSE<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/solar-energy-stocks\">Solar Energy Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/psu-stocks-list\">PSU Stocks List<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-long-term-stocks-to-invest\">Long Term<\/a>&nbsp;<\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-penny-stocks-below-100-rs\">Below 100 rs<\/a><\/td><td><a href=\"https:\/\/univest.in\/web-stories\/top-5-penny-stocks-under-re-1\">Top 5 Penny Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-fundamentally-strong-stocks\">For Long-Term<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-hospitality-stocks\">Hospitality Sector<\/a>&nbsp;<\/td><td><a href=\"https:\/\/univest.in\/blogs\/psu-stocks\">PSU Stocks in 2025<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-bike-stocks\">Best Bike Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-penny-stocks\">For 2025<\/a><\/td><td><a href=\"https:\/\/univest.in\/web-stories\/best-penny-stocks-to-invest-in-india\">Best Penny Stocks in India<\/a><\/td><td><a href=\"https:\/\/www.univest.in\/blogs\/penny-shares\">Penny Shares<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/hotel-stocks\">Hotel Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/top-government-stocks-in-india\">Government Stocks in 2024<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/top-liquor-stocks-in-india-2\">Best Liquor Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/multibagger-stocks-below-100\">High Growth Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-fundamentally-strong-penny-stocks\">For 2025<\/a><\/td><td><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-10-agriculture-stocks-in-india-2025\">Agriculture Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/government-stocks-list\">Government Stocks List<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/best-railway-stocks\">Best Railway Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/web-stories\/multibagger-stocks-under-rs-500-india-2024\">Under 500<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/penny-stocks\">Penny Stocks<\/a>&nbsp;<\/td><td><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-pharma-stocks\">Pharma Sector<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/government-stocks-in-india\">Government Stocks in 2025<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/auto-sector-stocks\">Best Auto Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/blogs\/top-10-multibagger-penny-stocks-for-2026\">For 2026<\/a><\/td><td><\/td><td><\/td><td><a href=\"https:\/\/univest.in\/blogs\/best-oil-and-gas-stocks\">Oil and Gas Sector<\/a><\/td><td><\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explore_Current_and_Previous_IPOs\"><\/span><strong>Explore Current and Previous IPOs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Company<\/strong><\/td><td><strong>Opening Date&nbsp;<\/strong><\/td><td><strong>Closing Date<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/arisinfra-solutions-ipo\">Arisinfra Solutions Limited<\/a>&nbsp;<\/td><td>20th March 2025&nbsp;<\/td><td>25th March 2025&nbsp;<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/paradeep-parivahan-ipo\">Paradeep Parivahan Limited<\/a>&nbsp;<\/td><td>17th March 2025&nbsp;<\/td><td>19th March 2025&nbsp;<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/divine-hira-jewellers-ipo-review\">Divine Hira Jewellers Limited<\/a>&nbsp;<\/td><td>17th March 2025&nbsp;<\/td><td>19th March 2025<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/super-iron-foundry-ipo\">Super Iron Foundry Limited<\/a><\/td><td>11th March 2025&nbsp;<\/td><td>13th March 2025&nbsp;<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/pdp-shipping-ipo\">PDP Shipping &amp; Projects Limited<\/a><\/td><td>10th March 2025&nbsp;<\/td><td>12th March 2025<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/naps-global-india-ipo\">NAPS Global India Limited<\/a><\/td><td>4th March 2025&nbsp;<\/td><td>6th March 2025&nbsp;<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/balaji-phosphates-ipo\">Balaji Phosphates Limited<\/a>&nbsp;<\/td><td>28th February 2025&nbsp;<\/td><td>04th March 2025<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/shreenath-paper-ipo\">Shreenath Paper Products Limited<\/a><\/td><td>25th February 2025&nbsp;<\/td><td>28th February 2025<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/nukleus-office-solutions-ipo\">Nukleus Office Solutions Limtied<\/a>&nbsp;<\/td><td>24th February 2025&nbsp;<\/td><td>27th February 2025<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/beezaasan-explotech-ipo\">Beezasan Explotech Limited<\/a>&nbsp;<\/td><td>21th February 2025&nbsp;<\/td><td>25th February 2025&nbsp;<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/hp-telecom-india-ipo\">HP Telecom India Limited<\/a>&nbsp;<\/td><td>20th February 2025&nbsp;<\/td><td>24th February 2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Univest_Screeners\"><\/span><strong>Univest Screeners<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Exclusive<\/strong><\/td><td><strong>Indices<\/strong><\/td><td><strong>Breakouts<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/short-term-verdict-buy\">Buy in Short Term<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-smlcap-100\">Nifty Small Cap 100<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/daily-fresh-breakouts\">Daily Fresh Breakouts<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/long-term-verdict-buy\">Buy in Long Term<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-midcap\">Nifty Midcap<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/weekly-breakouts\">Weekly Breakouts<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/fii-holding\">FII Holdings Change<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-bank\">Nifty Bank<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/oversold-stocks\">Oversold Stocks<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/golden-crossover\">Golden Crossover<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/sensex\">Sensex<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nearing-breakout\">Nearing Breakout<\/a><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/upcoming-dividents\">Upcoming Dividends<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-fin-service\">Nifty Fin Service<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/dii-holding\">DII Holdings Change<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/bankex\">Bankex<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/highest-dividend-paying-stocks\">High Dividend Stocks<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty-midcap-100\">Nifty Mid Cap 100<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/top-results-to-watch\">Earnings Announced<\/a><\/td><td><a href=\"https:\/\/univest.in\/screeners\/nifty50\">Nifty 50<\/a><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/fundamentally-strong-stocks\">Fundamentally Strong&nbsp;<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Top Gainers<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/top-losers\">Top Losers<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/low-debt-mid-cap\">Low Debt Mid Caps<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/cash-rich-small-cap\">Cash-Rich Small Caps<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/volume-shockers\">Volume Shockers<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/52-week-high\">52-Week High&nbsp;<\/a><\/td><td><\/td><td><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/screeners\/52-week-low\">52-Week Low<\/a><\/td><td><\/td><td><\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explore_Webstories_on_Univest\"><\/span><strong>Explore Webstories on Univest&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>1. <\/strong><a href=\"https:\/\/univest.in\/web-stories\/best-time-to-buy-dividend-stocks\/\"><strong>Best Time To Buy Dividend Stocks<\/strong><\/a><\/p><p><strong>2. <\/strong><a href=\"https:\/\/univest.in\/web-stories\/how-rbi-policies-affect-dividend-stocks\/\"><strong>How RBI Policies Affect Dividend Stocks<\/strong><\/a><\/p><p><strong>3. <\/strong><a href=\"https:\/\/univest.in\/web-stories\/can-dividend-stocks-beat-inflation\/\"><strong>Can Dividend Stocks Beat Inflation<\/strong><\/a><\/p><p><strong>4. <\/strong><a href=\"https:\/\/univest.in\/web-stories\/what-is-the-dividend-aristocrat-list\/\"><strong>What Is The Dividend Aristocrat List<\/strong><\/a><\/p><p><strong>5. <\/strong><a href=\"https:\/\/univest.in\/web-stories\/which-indian-psus-offer-the-best-dividends\/\"><strong>Which Indian Psus Offer The Best Dividends<\/strong><\/a><\/p><p><strong>6. <\/strong><a href=\"https:\/\/univest.in\/web-stories\/large-cap-vs-small-cap-dividend-stocks\/\"><strong>Large Cap Vs Small Cap Dividend Stocks<\/strong><\/a><\/p><p><strong><em>Disclaimer: <\/em><\/strong><em>This is for general information and education purposes only. The Securities quoted (if any) are for illustration only and are not recommendatory. Past performance does not guarantee any future returns. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Accretion Pharmaceuticals IPO is all set to open for bidding on 14th May 2025. It is a bookbuilding IPO consisting of a fresh issue of 29.46 lakh shares worth \u20b929.75 crores. The issue will be listed on NSE and SME on its tentative listing date, 21st May 2025.\u00a0 Accretion Pharmaceuticals IPO Details&nbsp; Accretion Pharmaceuticals IPO<\/p>\n","protected":false},"author":23,"featured_media":40579,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-40566","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"_edit_lock":["1747137571:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_seo_score":["90"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_focus_keyword":["Accretion Pharmaceuticals IPO"],"_wp_page_template":["default"],"rank_math_title":["Accretion Pharmaceuticals IPO GMP | Should You Apply or Avoid?"],"rank_math_description":["Get Accretion Pharmaceuticals IPO GMP, subscription, price, lot size, and listing details. Should you park funds in the Accretion Pharmaceuticals IPO in 2025? Read to know!"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_primary_category":["842"],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/accretion-pharmaceuticals-ipo"],"rank_math_analytic_object_id":["1945"],"_thumbnail_id":["40579"],"amazonS3_cache":["a:12:{s:75:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/Pharmaceuticals-image-2.jpg\";a:2:{s:2:\"id\";i:40580;s:11:\"source_type\";s:13:\"media-library\";}s:84:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/Pharmaceuticals-image-2-1024x536.jpg\";a:2:{s:2:\"id\";i:40580;s:11:\"source_type\";s:13:\"media-library\";}s:107:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2.jpg\";a:2:{s:2:\"id\";i:40580;s:11:\"source_type\";s:13:\"media-library\";}s:116:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171823\/Pharmaceuticals-image-2-1024x536.jpg\";a:2:{s:2:\"id\";i:40580;s:11:\"source_type\";s:13:\"media-library\";}s:75:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/Pharmaceuticals-image-3.jpg\";a:2:{s:2:\"id\";i:40582;s:11:\"source_type\";s:13:\"media-library\";}s:84:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/Pharmaceuticals-image-3-1024x536.jpg\";a:2:{s:2:\"id\";i:40582;s:11:\"source_type\";s:13:\"media-library\";}s:107:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3.jpg\";a:2:{s:2:\"id\";i:40582;s:11:\"source_type\";s:13:\"media-library\";}s:116:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171849\/Pharmaceuticals-image-3-1024x536.jpg\";a:2:{s:2:\"id\";i:40582;s:11:\"source_type\";s:13:\"media-library\";}s:75:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/Pharmaceuticals-image-4.jpg\";a:2:{s:2:\"id\";i:40583;s:11:\"source_type\";s:13:\"media-library\";}s:84:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/05\/Pharmaceuticals-image-4-1024x536.jpg\";a:2:{s:2:\"id\";i:40583;s:11:\"source_type\";s:13:\"media-library\";}s:107:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4.jpg\";a:2:{s:2:\"id\";i:40583;s:11:\"source_type\";s:13:\"media-library\";}s:116:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171915\/Pharmaceuticals-image-4-1024x536.jpg\";a:2:{s:2:\"id\";i:40583;s:11:\"source_type\";s:13:\"media-library\";}}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/05\/13171743\/Pharmaceuticals-image-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/40566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=40566"}],"version-history":[{"count":3,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/40566\/revisions"}],"predecessor-version":[{"id":40586,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/40566\/revisions\/40586"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/40579"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=40566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=40566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=40566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}